tumor tissues; adjacent non-tumoral tissues
-
ceRNA regulation (other); NF-kappaB (other); EGFR (other); immune regulation (other); inflammation (other)
RT-qPCR; Clinical Sample Validation; ROC Analysis; Bioinformatics Analysis
significant association with pathological T staging; ROC AUC=0.77 (80% sensitivity, 75% specificity) suggesting biomarker potential
SCAR/mc-COX2 (mc-COX2; hsa-circ-0089762) is significantly down-regulated in CRC tumor tissues and is suggested to act as a tumor suppressor and potential diagnostic biomarker (AUC=0.77). The study predicts a SCAR/mc-COX2-centered ceRNA network involving five miRNAs (including hsa-miR-938 and hsa-miR-1249) and multiple target mRNAs (e.g., MGLL, FAM107A, PLCG2), and also predicts interactions with several RBPs.
0.459
Pathological expression of mitochondrial genome-derived circRNA SCAR/mc-COX2 and its ceRNA network in colorectal cancer: implications for clinical significance.
combined biological and clinical study